Cite
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
MLA
Sánchez-Díaz, M., et al. “Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.” Actas Dermo-Sifiliograficas, vol. 115, no. 3, Mar. 2024, pp. 237–45. EBSCOhost, https://doi.org/10.1016/j.ad.2023.10.016.
APA
Sánchez-Díaz, M., Flórez, Á., Ara-Martín, M., Arias-Santiago, S., Botella-Estrada, R., Cañueto, J., Carretero-Hernández, G., Coto-Segura, P., de Eusebio-Murillo, E., García-Latasa de Araníbar, F. J., García-Patos Briones, V., Gardeazabal García, J., Gómez-Fernández, C., Hernández-Ostiz, S., Izu Belloso, R., López-Ávila, A., Manchado López, P., Martín-Santiago, A., Martinez de Espronceda Ezquerro, I., … Carrascosa-Carrillo, J. M. (2024). Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study. Actas Dermo-Sifiliograficas, 115(3), 237–245. https://doi.org/10.1016/j.ad.2023.10.016
Chicago
Sánchez-Díaz, M, Á Flórez, M Ara-Martín, S Arias-Santiago, R Botella-Estrada, J Cañueto, G Carretero-Hernández, et al. 2024. “Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.” Actas Dermo-Sifiliograficas 115 (3): 237–45. doi:10.1016/j.ad.2023.10.016.